Can molecular markers predict local, regional and distant metastasis in head and neck cancer?

Nature Clinical Practice Oncology

Volumn 2, Issue 3, 2005, Pages 132-133

  Haffty, Bruce G ^a  

^a YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Competing risks; Head and neck cancer; Molecular biomarkers; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; CYCLIN D1; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

AGE; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; GENDER; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 20444438442     PISSN: 17434254     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncponc0102     Document Type: Short Survey

References (5)

1. Smith B and Haffty BG (2002) Prognostic factors in head and neck cancer. In Head and Neck Cancer: A Multidisciplinary Approach, 2nd ed (Eds Harrison L et al.) Philadelphia: Lippincott-Raven Publishers
2. Cho EI et al. (2004) Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy. Laryngoscope 114: 2001-2008
3. Harari PM et al. (2001) Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys 49: 427-433
4. Smith BD et al. (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18: 2046-2052
5. Eriksen JG et al. (2004) Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother Oncol 72: 275-282